Henry Schein is a Fortune 500 company and one of the global leaders in its industry, providing healthcare solutions, as well ...

Dental care supplier Henry Schein advanced in Monday trading as investors bet that Robert F. Kennedy Jr., President-elect ...

Analyst Erin Wright of Morgan Stanley maintained a Sell rating on Henry Schein (HSIC – Research Report), retaining the price target of ...

Good morning, ladies and gentlemen, and welcome to Henry Schein's Third Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a ...

Henry Schein (HSIC – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Michael ...

Dental care supplier Henry Schein advanced in Monday trading as investors bet that Robert F. Kennedy Jr., President-elect ...

Analysts' ratings for Henry Schein (NASDAQ ... engaged in combining global dental and medical businesses and distributes consumable products, small equipment, laboratory products, and Vitamins.

The dental supplies firm raised the lower end of its 2024 adjusted earnings projection, and now anticipates a range between $4.74 and $4.82 a share, compared with the prior $4.70-to-$4.82 a share ...

Henry Schein posts Q3 adjusted EPS of $1.23, topping forecasts, while sales of $3.17 billion fall short. The company revises ...

Henry Schein Inc. closed $12.62 short of its 52-week high ($82.63), which the company reached on February 27th.

On Tuesday, Henry Schein Inc. (NASDAQ ... market share in our dental and medical distribution businesses following last year's cyber incident. Our dental equipment business is showing ongoing ...